CHEARS Update Press Releases

The U.S. Food and Drug Administration (FDA) has issued an important public safety alert warning consumers not to use expired Amazon Basic Care Levonorgestrel 1.5 mg emergency contraceptive tablets that were reportedly shipped to customers past their labeled expiration dates. .....

In modern cancer care, one of the most important advances has been the shift from broad chemotherapy to targeted therapy. Trastuzumab is a landmark example of this change. It is a recombinant humanized monoclonal antibody that specifically binds to the HER2 receptor, a protein that can drive aggressive tumor growth when overexpressed. The approval of trastuzumab in 150 mg and 420 mg lyophilized powder presentations on 05-May-2026 adds to the practical availability of this therapy in oncology settings, especially where controlled infusion-based treatment is standard......

The U.S. Food and Drug Administration (FDA) has taken a significant step in the fight against pancreatic cancer by permitting expanded access to daraxonrasib, an investigational drug for patients with previously treated metastatic pancreatic ductal adenocarcinoma (PDAC). This move, announced on April 30, 2026, allows eligible patients who have exhausted standard therapies to receive the drug outside clinical trials, under the FDA's expanded access program (EAP). This decision underscores the urgent need for effective treatments for pancreatic cancer, a disease with a notoriously poor prognosis and high mortality......